Cargando…
Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia
BACKGROUND: Although the presence of physical signs [tendon xanthomas and/or corneal arcus (TX/CA)], are associated with the risk of coronary artery disease in patients with heterozygous familial hypercholesterolemia (HeFH), their relationship with genotypes and clinical characteristics has not been...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650321/ https://www.ncbi.nlm.nih.gov/pubmed/34876165 http://dx.doi.org/10.1186/s12967-021-03166-w |
_version_ | 1784611176141815808 |
---|---|
author | Liu, Ming-Ming Peng, Jia Guo, Yuan-Lin Zhu, Cheng-Gang Wu, Na-Qiong Xu, Rui-Xia Dong, Qian Li, Jian-Jun |
author_facet | Liu, Ming-Ming Peng, Jia Guo, Yuan-Lin Zhu, Cheng-Gang Wu, Na-Qiong Xu, Rui-Xia Dong, Qian Li, Jian-Jun |
author_sort | Liu, Ming-Ming |
collection | PubMed |
description | BACKGROUND: Although the presence of physical signs [tendon xanthomas and/or corneal arcus (TX/CA)], are associated with the risk of coronary artery disease in patients with heterozygous familial hypercholesterolemia (HeFH), their relationship with genotypes and clinical characteristics has not been fully determined. This study aimed to examine the association of TX/CA with genetic mutation, lipid- and inflammation-related markers, the severity of coronary stenosis or calcification, and cardiovascular events (CVEs) in patients with HeFH. METHODS: LDLR, APOB, and PCSK9 genes were screened in 523 HeFH patients, and patients with TX/CA (n = 50) were 1:4 propensity score-matched to patients without TX/CA (n = 200) to adjust for age and sex. Laboratory markers (proprotein convertase subtilisin/kexin type 9 [PCSK9], lipoprotein(a) and high-sensitivity C-reactive protein [hsCRP]), computed tomography angiography, coronary angiography, and follow-up for CVEs were performed. RESULTS: Patients with physical signs had significantly higher low-density lipoprotein cholesterol levels; higher PCSK9 or hsCRP concentrations; more LDLR positive mutations; and higher prevalence of high tertiles of Gensini, SYNTAX and Jeopardy scores as well as coronary artery calcium scores than did those without. Over an average follow-up of 3.7 years, the incidence of CVEs was significantly higher in patients with TX/CA (log-rank p < 0.001). Patients with physical signs and mutation positivity had threefold higher risks of CVEs (adjusted hazard ratio 3.34, 95% confidence interval 1.04–10.72, p = 0.024). CONCLUSIONS: Physical signs were associated with genotypes and phenotypes, and worse outcomes in patients with HeFH, suggesting that these signs may help in risk stratification in these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-021-03166-w. |
format | Online Article Text |
id | pubmed-8650321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86503212021-12-07 Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia Liu, Ming-Ming Peng, Jia Guo, Yuan-Lin Zhu, Cheng-Gang Wu, Na-Qiong Xu, Rui-Xia Dong, Qian Li, Jian-Jun J Transl Med Research BACKGROUND: Although the presence of physical signs [tendon xanthomas and/or corneal arcus (TX/CA)], are associated with the risk of coronary artery disease in patients with heterozygous familial hypercholesterolemia (HeFH), their relationship with genotypes and clinical characteristics has not been fully determined. This study aimed to examine the association of TX/CA with genetic mutation, lipid- and inflammation-related markers, the severity of coronary stenosis or calcification, and cardiovascular events (CVEs) in patients with HeFH. METHODS: LDLR, APOB, and PCSK9 genes were screened in 523 HeFH patients, and patients with TX/CA (n = 50) were 1:4 propensity score-matched to patients without TX/CA (n = 200) to adjust for age and sex. Laboratory markers (proprotein convertase subtilisin/kexin type 9 [PCSK9], lipoprotein(a) and high-sensitivity C-reactive protein [hsCRP]), computed tomography angiography, coronary angiography, and follow-up for CVEs were performed. RESULTS: Patients with physical signs had significantly higher low-density lipoprotein cholesterol levels; higher PCSK9 or hsCRP concentrations; more LDLR positive mutations; and higher prevalence of high tertiles of Gensini, SYNTAX and Jeopardy scores as well as coronary artery calcium scores than did those without. Over an average follow-up of 3.7 years, the incidence of CVEs was significantly higher in patients with TX/CA (log-rank p < 0.001). Patients with physical signs and mutation positivity had threefold higher risks of CVEs (adjusted hazard ratio 3.34, 95% confidence interval 1.04–10.72, p = 0.024). CONCLUSIONS: Physical signs were associated with genotypes and phenotypes, and worse outcomes in patients with HeFH, suggesting that these signs may help in risk stratification in these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-021-03166-w. BioMed Central 2021-12-07 /pmc/articles/PMC8650321/ /pubmed/34876165 http://dx.doi.org/10.1186/s12967-021-03166-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Liu, Ming-Ming Peng, Jia Guo, Yuan-Lin Zhu, Cheng-Gang Wu, Na-Qiong Xu, Rui-Xia Dong, Qian Li, Jian-Jun Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia |
title | Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia |
title_full | Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia |
title_fullStr | Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia |
title_full_unstemmed | Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia |
title_short | Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia |
title_sort | relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650321/ https://www.ncbi.nlm.nih.gov/pubmed/34876165 http://dx.doi.org/10.1186/s12967-021-03166-w |
work_keys_str_mv | AT liumingming relationsofphysicalsignstogenotypelipidandinflammatorymarkerscoronarystenosisorcalcificationandoutcomesinpatientswithheterozygousfamilialhypercholesterolemia AT pengjia relationsofphysicalsignstogenotypelipidandinflammatorymarkerscoronarystenosisorcalcificationandoutcomesinpatientswithheterozygousfamilialhypercholesterolemia AT guoyuanlin relationsofphysicalsignstogenotypelipidandinflammatorymarkerscoronarystenosisorcalcificationandoutcomesinpatientswithheterozygousfamilialhypercholesterolemia AT zhuchenggang relationsofphysicalsignstogenotypelipidandinflammatorymarkerscoronarystenosisorcalcificationandoutcomesinpatientswithheterozygousfamilialhypercholesterolemia AT wunaqiong relationsofphysicalsignstogenotypelipidandinflammatorymarkerscoronarystenosisorcalcificationandoutcomesinpatientswithheterozygousfamilialhypercholesterolemia AT xuruixia relationsofphysicalsignstogenotypelipidandinflammatorymarkerscoronarystenosisorcalcificationandoutcomesinpatientswithheterozygousfamilialhypercholesterolemia AT dongqian relationsofphysicalsignstogenotypelipidandinflammatorymarkerscoronarystenosisorcalcificationandoutcomesinpatientswithheterozygousfamilialhypercholesterolemia AT lijianjun relationsofphysicalsignstogenotypelipidandinflammatorymarkerscoronarystenosisorcalcificationandoutcomesinpatientswithheterozygousfamilialhypercholesterolemia |